William Blair Downgrades ResMed (RMD) to Market Perform
William Blair downgraded ResMed (NYSE: RMD) from Outperform to Market ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
